title: New successful treatment with disinfectant for atopic dermatitis.
abstract: For the treatment of atopic dermatitis, a variety of therapies are used including folk medicine. At present, there is no single treatment which is effective to cure the symptoms of atopic dermatitis completely in all patients. We are drawing attention to the high isolation rate of Staphylococcus aureus when starting disinfectant treatment combined with topical steroid therapies for the purpose of killing S. aureus. As a result, we examined many patients in whom almost a complete remission was obtained even after short periods of therapy, though it had been difficult to obtain improvement by conventional treatments. In many patients, IgE values and reagin antibody titer decrease dramatically soon after starting treatment. As a disinfectant, 10% povidone-iodine solution was used. We investigated also the effect of iodine contained in the povidone-iodine solution on the thyroid gland.
authors.affiliation: Department of Pediatrics, Chiba Municipal Hospital, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Sugimoto
authors.forename: H
authors.initials: H
authors.lastname: Kuroki
authors.forename: M
authors.initials: M
authors.lastname: Kanazawa
authors.forename: T
authors.initials: T
authors.lastname: Kurosaki
authors.forename: H
authors.initials: H
authors.lastname: Abe
authors.forename: Y
authors.initials: Y
authors.lastname: Takahashi
authors.forename: N
authors.initials: N
authors.lastname: Ishiwada
authors.forename: Y
authors.initials: Y
authors.lastname: Nezu
authors.forename: A
authors.initials: A
authors.lastname: Hoshioka
authors.forename: T
authors.initials: T
authors.lastname: Toba
mesh_terms: D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D004643:Emollients / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007455:Iodine / Q000032:analysis; D007466:Iodophors / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008519:Medicine, Traditional; D016106:Methicillin Resistance; D017060:Patient Satisfaction; D010577:Petrolatum / Q000627:therapeutic use; D011206:Povidone-Iodine / Q000008:administration & dosage / Q000627:therapeutic use*; D011935:Reagins / Q000032:analysis; D012074:Remission Induction; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000276:immunology; D013211:Staphylococcus aureus / Q000276:immunology / Q000302:isolation & purification; D011795:Surveys and Questionnaires; D013961:Thyroid Gland / Q000187:drug effects; D013972:Thyrotropin / Q000032:analysis; D013974:Thyroxine / Q000032:analysis; D014284:Triiodothyronine / Q000032:analysis
chemical_list: D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D004643:Emollients; D005938:Glucocorticoids; D007466:Iodophors; D011935:Reagins; D014284:Triiodothyronine; D007073:Immunoglobulin E; D010577:Petrolatum; D011206:Povidone-Iodine; D013972:Thyrotropin; D007455:Iodine; D013974:Thyroxine